NMR & Bio-NMR expansion CortecNet’s long-standing Bruker partnership and expansion into solid-state NMR consulting, plus developed strategies for labeled proteins and diverse expression systems, highlights a strong opportunity to sell advanced NMR services and labeled biomolecules to pharma, biotech, and academic labs seeking robust characterization capabilities.

Preclinical & Clinical materials With capabilities extending to materials for preclinical and clinical applications in MS, PET, and MRI, there is a compelling cross-sell path to contract research organizations, pharma companies, and imaging core facilities seeking labeled compounds and related imaging agents.

Global footprint Established offices in Paris-Saclay, New York, and Bangkok indicate a global reach and potential for regional account management, logistics capabilities, and localized sales outreach to accelerate adoption in multiple markets.

CgpM ready production Recent state-of-the-art R&D and production facility with cGMP synthesis readiness suggests near-term capacity to scale customized labeled compounds, enabling upsell to large customers requiring compliant, scalable manufacturing for clinical studies.

Diverse tech stack Exposure to e-commerce and digital marketing tools (Magento, Google Analytics, LinkedIn Sales Navigator) combined with scientific credibility offers a straightforward pathway for targeted marketing, partner programs, and digital outreach to laboratories and procurement teams.